AIM IMMUNOTECH INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AIM IMMUNOTECH INC. stock issued during period, value, other for the quarter ending 2026-06-30 was $5.09M.
- AIM IMMUNOTECH INC. stock issued during period, value, other for the quarter ending 2026-03-31 was $1.66M, a 269.33% increase year-over-year.
- AIM IMMUNOTECH INC. stock issued during period, value, other for the quarter ending 2025-03-31 was $450.00K.
- AIM IMMUNOTECH INC. stock issued during period, value, other for the quarter ending 2024-09-30 was $330.00K, a 560.00% increase year-over-year.
- AIM IMMUNOTECH INC. stock issued during period, value, other for fiscal 2025 was $60.00K, a 91.25% decline from fiscal 2024.
- AIM IMMUNOTECH INC. stock issued during period, value, other for fiscal 2024 was $686.00K, a 182.30% increase from fiscal 2023.
- AIM IMMUNOTECH INC. stock issued during period, value, other for fiscal 2023 was $243.00K.
- AIM IMMUNOTECH INC. stock issued during period, value, other for fiscal 2018 was $330.00K, a 63.25% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $5.09M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.66M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $60.00K 10-K · filed 2026-03-27 | |
| 2025-03-31 | $450.00K 10-Q · filed 2025-11-17 | |
| 2024-12-31 | $686.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $330.00K 10-Q · filed 2024-11-14 | |
| 2023-12-31 | $243.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $50.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $50.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $82.00K 10-Q · filed 2024-11-14 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2019-03-31 | $5.31M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $330.00K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $898.00K 10-K · filed 2019-04-01 | |
| 2016-12-31 | $50.00K 10-K · filed 2018-03-30 | |
| 2009-12-31 | $55.57M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |